Market research
HMD.AU HeraMED Limited
AU AUD Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 44M
- P/E ratio
- Not available
- Analyst target
- 0.11
- Dividend yield
- Not available
- Beta
- 0.05
Profile
Company facts
- Exchange
- AU
- Currency
- AUD
- Sector
- Healthcare
- Industry
- Medical Devices
- ISIN
- AU0000028367
- Market cap
- 44M
- P/E ratio
- Not available
- Analyst target
- 0.11
- Dividend yield
- Not available
- Beta
- 0.05
About
About HeraMED Limited
HeraMED Limited, a medical data and technology company, develops, manufactures, and sells home-based maternity monitoring technology in Australia and the United States. It provides HeraBEAT, a medical device for fetal and maternal heart rate used by pregnant women; and HeraCARE, a digital maternity and women's health platform that focuses on improving clinical outcomes while supporting more efficient and accessible models of care. The company has a collaboration agreement with Mayo Clinic. HeraMED Limited was founded in 2011 and is based in Hawthorn East, Australia.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the HMD.AU discussion.
5 years, 4 months ago
HeraMED Limited is currently in a long term uptrend where the price is trading 73.5% above its 200 day moving average.
From a valuation standpoint, the stock is 4.7% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 269.6.
HeraMED Limited's total revenue sank by 94.2% to $3K since the same quarter in the previous year.
Its net income has dropped by 13.9% to $-2M since the same quarter in the previous year.
Finally, its free cash flow grew by 7.8% to $-782K since the same quarter in the previous year.
Based on the above factors, HeraMED Limited gets an overall score of 2/5.